Exchange: NYSE·Updated 12:00 PM EST
CL logo

CL Colgate-Palmolive Co.

$97.64
$1.08
(1.12%)
Today
Reported EarningsOct 30
Mkt Cap$76.76B
Vol1.09M

About CL

Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care, and Pet Nutrition segments. The Oral, Personal, and Home Care segment includes toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. The Pet Nutrition segment offers specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.
56

Bullish Sentiment

How do you feel about CL?

MurdaCwrote
$CL $SPY Ummm, the Colgate earnings was last week. Great to listen to a weed stock earnings call on a boomer divy stock. This will surely confuse the octogenerians
2
shoc24
$CL is ranked #9 in consumer defensive quality with a score of 88 after today's selloff. I posted these rankings earlier, but the data just refreshed. It may not feel like it after today's S show, but a down day can be the right time to invest. I used Stock Meadow's Scoring model to find the next stock I'm buying.
shoc24
Rough, scary day in the market, and it's okay to feel it. Markets have bounced back from drops before, and I expect this one to as well. For me, days like this are for research, so I used Stock Meadow's scoring model to find the companies to buy. $CL is ranked #8 in consumer defensive quality with a score of 87.
shoc24
$CL is ranked #8 in consumer defensive quality with a score of 88. I used Stock Meadow's scoring model to review the results.
KryptonResearch14
$CL Colgate has already booked 346 million dollars in cumulative pre-tax charges under its productivity program, and 172 million dollars was still accrued at September 30 after cash payments in the first nine months. That cumulative total sits near the low end of the 350 to 550 million dollar program estimate in the 10-Q restructuring note.
ElliottwaveForecast
📉 $CL Outlook: Extension Higher Still Possible There is a possibility that the cycle from the 07.02.2026 low has already completed at the wave 1 high, as the rally from the July low has unfolded in a clear five-wave impulsive structure. However, our preferred view remains that Crude Oil $CL can still see further upside within wave (5), as outlined in our latest updates. With Gold and Silver still expected to extend lower within their broader corrective cycles, the commodity complex could support more higher in CL before a more meaningful reversal develops. ⚠️ Until proven otherwise, we continue to favour the potential for an extension higher in wave (5). #CL #CrudeOil #OilTrading #Commodities #ElliottWave #TechnicalAnalysis #Futures #Trading #Gold #Silver
MarketKingdoms
$CL Q3 '26 organic sales grew 4.5% YoY across all categories, led by emerging markets and Hill's. Gross margin expanded despite ~300 bps material cost pressure, offset by >290 bps productivity, pricing and mix. FY26 gross margin outlook raised from flat to growth; FCF +7% YTD. Catalysts in play - Hill's organic sales +6.5% ex-private label; gross margin +170 bps. - Latin America organic growth +6%, with volume +3.9%. - India and Brazil grew double digits; China high single digits. - promoAI rollout targets better promotion ROI and pricing. - $2.2B returned to shareholders YTD; savings run through 2028. Risks to watch - US recovery remains unfinished, without a firm timetable. - ~$300M cost inflation; logistics pressure extends into 2027. - FX headwinds from emerging-market currencies. - Mexico retailer disruptions may persist until year-end. - China physical retail remains weak; social commerce drives growth. - Hill's category growth subdued; fresh pet food rollout gradual. - '27 guidance deferred
openclassaction2
$CL: filed a Tom's of Maine claim by July 6? Tiers: average MSRP for 1 toothpaste per household, no proof, or full refund for up to 3 with proof. $2.9M fund, payments expected mid-November. Claims closed. Open Class Actions.
openclassaction2
$CL: the Tom's of Maine case traces to a May 2024 FDA inspection in Sanford. Tom's reviewed about 4,900 toothpastes and found no safety risk, plaintiffs allege deceptive marketing. Claims closed, payments pending. Open Class Actions.
StocktwitsEarnings
$CL Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $0.97 up 6.59% YoY • Reported revenue of $5.37B up 4.64% YoY • For full year 2026, Colgate-Palmolive now expects net sales up 4% to 5%, GAAP and Base Business gross profit margin up, and Base Business earnings per share growth of 5% to 7%.
LiveSquawk
$CL | Colgate-Palmolive Q3 2026 Earnings - Sales: $5,369M (est $5,334M) - Adjusted EPS: $0.97 (est $0.93) - Sees FY Net Sales Growth: 4% To 5% - Sees FY2026 Base Business Gross Profit Margin: Up - Sees FY2026 Base Business EPS Growth: 5% To 7%
MurdaCwrote
$CL With 23 shares, annual toothpaste costs are covered by the dividend Position created I can feel myself finally morphing into a boomer. The power
openclassaction2
$CL: a leftover rule in Tom's of Maine: if approved claims total less than the $2.9M fund, the remaining money goes to Equal Justice Works, not back to Colgate. Claims closed, payments pending. Open Class Actions.
KryptonResearch14
$CL reports Friday before the open. Zacks consensus is $0.92 of EPS, up 1.1% from a year ago, on 5.33 billion dollars of revenue, up 3.9%. Q2 set a pretty high bar. Base Business EPS rose 8% to $0.99 and gross margin expanded 140 basis points to 61.5%, and management raised the full year Base Business EPS guide to mid-single-digit growth. North America was the soft spot in Q2, sales down 3.0% there while Latin America grew 13.7%.
topstockalerts
Colgate-Palmolive shares could move 2.9% when the consumer-products company reports earnings on October 30 before the market opens, according to Bloomberg options data. The stock’s actual price movement exceeded the options-implied move in four of its last eight earnings announcements. Recent results have produced mixed reactions. On July 31, shares moved 1.4%, below the implied 2.5% move, while the May 1 report triggered a 4.2% move versus an expected 3.4%. On January 30, the stock moved 5.2%, substantially exceeding the implied 2.2%. Historical reactions also show a downside tendency. Shares fell 5.6% on August 1, 2025, compared with an implied 3.6% move, and dropped 4.9% on October 25, 2024, versus an expected 3.5%. However, several other reports saw smaller declines than options had anticipated, including a 1.8% drop on October 31, 2025, against an implied 3.7% move, and a 1.4% decline on January 31, 2025, versus 4.1%. $CL
peloswing
$CL saw some dated OTM call flow today - $38K+ of the $95 call for Jan. 2028 - $16K+ of the $110 call for Jan. 2028
BigAllergies
$CL hadn't closed above its 200-day since Sep 10. It did today. Colgate-Palmolive is an Average 6 on the Quality Score, #5 of 9 in its industry.

Advertisement|Remove ads.